Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia
- PMID: 18700216
- PMCID: PMC2801826
- DOI: 10.1192/bjp.bp.107.042630
Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia
Abstract
Background: Violence is an uncommon but significant problem associated with schizophrenia.
Aims: To compare antipsychotic medications in reducing violence among patients with schizophrenia over 6 months, identify prospective predictors of violence and examine the impact of medication adherence on reduced violence.
Method: Participants (n=1445) were randomly assigned to double-blinded treatment with one of five antipsychotic medications. Analyses are presented for the intention-to-treat sample and for patients completing 6 months on assigned medication.
Results: Violence declined from 16% to 9% in the retained sample and from 19% to 14% in the intention-to-treat sample. No difference by medication group was found, except that perphenazine showed greater violence reduction than quetiapine in the retained sample. Medication adherence reduced violence, but not in patients with a history of childhood antisocial conduct. Prospective predictors of violence included childhood conduct problems, substance use, victimisation, economic deprivation and living situation. Negative psychotic symptoms predicted lower violence.
Conclusions: Newer antipsychotics did not reduce violence more than perphenazine. Effective antipsychotics are needed, but may not reduce violence unrelated to acute psychopathology.
Comment in
-
Antipsychotic medications do not differ substantially in ability to reduce violent behaviour in people with schizophrenia.Evid Based Ment Health. 2009 Feb;12(1):13. doi: 10.1136/ebmh.12.1.13. Evid Based Ment Health. 2009. PMID: 19176772 No abstract available.
Similar articles
-
Impact of antipsychotic medication on family burden in schizophrenia: longitudinal results of CATIE trial.Schizophr Res. 2010 Feb;116(2-3):118-25. doi: 10.1016/j.schres.2009.09.026. Epub 2009 Oct 28. Schizophr Res. 2010. PMID: 19864114 Clinical Trial.
-
Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study.Am J Psychiatry. 2007 Mar;164(3):415-27. doi: 10.1176/ajp.2007.164.3.415. Am J Psychiatry. 2007. PMID: 17329466 Clinical Trial.
-
Impact of second-generation antipsychotics and perphenazine on depressive symptoms in a randomized trial of treatment for chronic schizophrenia.J Clin Psychiatry. 2011 Jan;72(1):75-80. doi: 10.4088/JCP.09m05258gre. Epub 2010 Sep 21. J Clin Psychiatry. 2011. PMID: 20868641 Free PMC article. Clinical Trial.
-
An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.Hum Psychopharmacol. 2011 Jan;26(1):81-5. doi: 10.1002/hup.1173. Epub 2011 Feb 9. Hum Psychopharmacol. 2011. PMID: 23055416 Review.
-
Pharmacological treatment of violence in schizophrenia.CNS Spectr. 2020 Apr;25(2):207-215. doi: 10.1017/S1092852919001226. Epub 2019 Jul 25. CNS Spectr. 2020. PMID: 31342892 Review.
Cited by
-
Claim of superiority of SGA in the treatment of aggressiveness in schizophrenia is not supported by data.Psychopharmacology (Berl). 2016 Jun;233(12):2419-20. doi: 10.1007/s00213-016-4302-1. Epub 2016 Apr 28. Psychopharmacology (Berl). 2016. PMID: 27125961 No abstract available.
-
Aggressive Behavior, Hostility, and Associated Care Needs in Patients With Psychotic Disorders: A 6-Year Follow-Up Study.Front Psychiatry. 2020 Jan 8;10:934. doi: 10.3389/fpsyt.2019.00934. eCollection 2019. Front Psychiatry. 2020. PMID: 31998154 Free PMC article.
-
Treatment of psychosis in prisons and violent recidivism.BJPsych Open. 2015 Nov 9;1(2):149-157. doi: 10.1192/bjpo.bp.115.000257. eCollection 2015 Oct. BJPsych Open. 2015. PMID: 27703740 Free PMC article.
-
Stigma and violence: isn't it time to connect the dots?Schizophr Bull. 2011 Sep;37(5):892-6. doi: 10.1093/schbul/sbr057. Epub 2011 Jun 7. Schizophr Bull. 2011. PMID: 21653276 Free PMC article.
-
Criminal behavior among persons with schizophrenia in rural China.Schizophr Res. 2010 Sep;122(1-3):213-8. doi: 10.1016/j.schres.2009.12.026. Epub 2010 Jan 13. Schizophr Res. 2010. PMID: 20067858 Free PMC article.
References
-
- Walsh E, Buchanan A, Fahy T. Violence and schizophrenia: examining the evidence. Br J Psychiatry 2002; 180: 490–5. - PubMed
-
- Swanson JW, Swartz MS, Elbogen EB. Effectiveness of atypical antipsychotic medications in reducing violent behavior among persons with schizophrenia in community-based treatment. Schizophr Bull 2004; 30: 3–20. - PubMed
-
- Buckley PF. The role of typical and atypical antipsychotic medications in the management of agitation and aggression. J Clin Psychiatry 1999; 60: 52–60. - PubMed
-
- Buckley PF, Bartell J, Donenwirth K, Lee S, Torigoe F, Schulz SC. Violence and schizophrenia: clozapine as a specific antiaggressive agent. Bull Am Acad Psychiatry Law 1995; 23: 607–11. - PubMed
-
- Citrome L, Krakowski M, Greenberg WM, Andrade E, Volavka J. Antiaggressive effect of quetiapine in a patient with schizoaffective disorder. J Clin Psychiatry 2001; 62: 901. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical